Cargando…

Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy

BACKGROUND: The study evaluates the frequency of and indications for bone-metastases (BM)-related surgery and/or radiotherapy in the palliative breast cancer (BC) situation and analyzes in which phase of the palliative disease course surgery and/or radiotherapy was applied. METHODS: 340 patients who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steinauer, Kirsten, Huang, Dorothy Jane, Eppenberger-Castori, Serenella, Amann, Esther, Güth, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723608/ https://www.ncbi.nlm.nih.gov/pubmed/26909298 http://dx.doi.org/10.1016/j.jbo.2014.05.001

Ejemplares similares

Radiotherapy in patients with distant metastatic breast cancer
por: Steinauer, Kirsten, et al.
Publicado: (2014)

Increased Level of Phosphorylated ShcA Measured by Chemiluminescence-Linked Immunoassay Is a Predictor of Good Prognosis in Primary Breast Cancer Expressing Low Levels of Estrogen Receptor
por: Cicenas, Jonas, et al.
Publicado: (2010)

HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer
por: Chandran, Vineesh Indira, et al.
Publicado: (2015)

Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples
por: Zanetti-Dällenbach, Rosanna, et al.
Publicado: (2006)

Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2
por: Cicenas, Jonas, et al.
Publicado: (2005)

Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer
por: Zhou, Yamei, et al.
Publicado: (2007)

Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome
por: Vuaroqueaux, Vincent, et al.
Publicado: (2007)

Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99
por: Eppenberger-Castori, Serenella, et al.
Publicado: (2020)

Re-Punching Tissue Microarrays Is Possible: Why Can This Be Useful and How to Do It
por: Lacombe, Aurélien, et al.
Publicado: (2015)

Locoregional progression-free survival of bone metastases from differentiated thyroid cancer
por: Luo, Jiaxin, et al.
Publicado: (2022)

Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer
por: Sadozai, Hassan, et al.
Publicado: (2021)

Locoregional tumor burden and risk of mortality in metastatic breast cancer
por: Yang, Sherry X., et al.
Publicado: (2022)

Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer
por: de Jong, Mees Hendrik Siert, et al.
Publicado: (2022)

Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells?
por: Sadanandam, Anguraj, et al.
Publicado: (2012)

Colorectal cancer – patterns of locoregional recurrence and distant metastases as demonstrated by FDG PET / CT
por: Purandare, Nilendu C, et al.
Publicado: (2010)

The role and indications of aggressive locoregional therapy in metastatic inflammatory breast cancer
por: Yan, Yi, et al.
Publicado: (2016)

Locoregional therapy in de novo metastatic breast cancer. The unanswered question
por: Cardoso, Maria-Joao, et al.
Publicado: (2021)

MicroRNA-1291 Is Associated With Locoregional Metastases in Patients With Early-Stage Breast Cancer
por: Escuin, Daniel, et al.
Publicado: (2020)

A visualized model for identifying optimal candidates for aggressive locoregional surgical treatment in patients with bone metastases from breast cancer
por: Tong, Yuexin, et al.
Publicado: (2023)

Locoregional and Distant Recurrence Patterns in Young versus Elderly Women Treated for Breast Cancer
por: Rudra, Soumon, et al.
Publicado: (2015)

ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibition
por: Scott, Gary K., et al.
Publicado: (2016)

Transcatheter Arterial Chemoembolization Is a Feasible Palliative Locoregional Therapy for Breast Cancer Liver Metastases
por: Cho, Sung W., et al.
Publicado: (2010)

Colorectal carcinoma infiltration by myeloperoxidase-expressing neutrophil granulocytes is associated with favorable prognosis
por: Hirt, Christian, et al.
Publicado: (2013)

Effects of Rapid On-Site Evaluation on Diagnostic Accuracy of Thyroid Fine-Needle Aspiration
por: Fawcett, Celia, et al.
Publicado: (2022)

Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis
por: Chen, Ming-Yuan, et al.
Publicado: (2013)

Locoregional treatment for colorectal liver metastases aiming for precision medicine
por: Maki, Harufumi, et al.
Publicado: (2023)

Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience
por: Montgomery, D A, et al.
Publicado: (2007)

Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis
por: Reinhorn, Daniel, et al.
Publicado: (2021)

Locoregional Therapy in De novo Metastatic Breast Cancer: A Retrospective Cohort Study
por: Jianna, Sun, et al.
Publicado: (2022)

Prognostic Factors in Patients with Metastatic Breast Cancer with Bone‐Only Metastases
por: Parkes, Amanda, et al.
Publicado: (2018)

Metastatic disease to the liver: Locoregional therapy strategies and outcomes
por: Zane, Kylie E, et al.
Publicado: (2021)

The pattern and treatment outcomes for rectal cancer with concurrent locoregional recurrence and distant metastases after total mesorectal excision
por: Chen, Yikuan, et al.
Publicado: (2022)

Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma
por: Barber, Brittany R, et al.
Publicado: (2013)

Pan-cancer gene expression analysis of tissue microarray using EdgeSeq oncology biomarker panel and a cross-comparison with HER2 and HER3 immunohistochemical analysis
por: Inaki, Koichiro, et al.
Publicado: (2022)

Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer
por: Serna, Garazi, et al.
Publicado: (2020)

The Place of Extensive Surgery in Locoregional Recurrence and Limited Metastatic Disease of Breast Cancer: Preliminary Results
por: Berlière, M., et al.
Publicado: (2015)

Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer
por: Zheng, Yajuan, et al.
Publicado: (2020)

Imaging in Locoregional Management of Breast Cancer
por: Kuhl, Christiane K., et al.
Publicado: (2020)

Reirradiation for Locoregional Recurrent Breast Cancer
por: Fattahi, Sayeh, et al.
Publicado: (2020)

Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer
por: Hassan, Md Sazzad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u1dsfssv08l9eelhlfl5ajrcgs